New Market Study Published: Algeria Pharmaceuticals & Healthcare Report Q1 2013
BMI View: We remain optimistic about Algeria's longer term potential as a pharmaceutical market, underpinned by economic and demographic factors. Our view is supported by a number of investments into the local manufacturing sector made by foreign players in recent months, in partnerships with local companies. However, the country does pose numerous operational risks, which will continue to hamper the development of its full potential until the deficiencies are successfully addressed.
View full press release